Yale spinout, Carogen, announces additional $6.2 million in funding from the Department of Defense (DoD)
Spring Health Notches A $190 Million Series C At A $2 Billion Valuation, Making CEO April Koh The Youngest Woman To Run A Unicorn
Yale Spinout Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
Prepared (co-founded by Michael Chime YC ’21, Dylan Gleicher YC ’21, and Neal Soni YC ’22) closes a $16 Million round
Yale spinout Allyx Therapeutics to Present Phase 1 Data for Lead Compound ALX-001 at the 16th Clinical Trials on Alzheimer's Disease Meeting
